Rentosertib

N/A

Report date: 2025/04/29 16:55:47
NME

Base Information

Drug NameRentosertib
Drug Alias NameISM-001-055ISM001-055INS018_055
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTRAF2 and NCK-interacting protein kinase inhibitors
TargetsTRAF2 and NCK-interacting protein kinase
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesInsilico Medicine Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInsilico Medicine LtdInSilico Medicine Hong Kong Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank